BioCentury | Dec 1, 2016
Clinical News

SER150: Ph IIa ongoing

...Norway Product: SER150 (formerly EV-077) Business: Renal Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
...of urinary thromboxane Status: Phase IIa ongoing Milestone: Phase IIa data (01/2017) Alicia Parker EV-077 SER150 Evolva Holding S.A. Serodus ASA Thromboxane receptor Thromboxane...
BioCentury | Jan 13, 2014
Company News

Evolva Holding, Serodus A/S deal

...agreement for a Phase II trial evaluating EV-077 in late 2014. EV-077 - an oral thromboxane receptor...
BioCentury | Oct 14, 2013
Company News

Evolva Holding, Serodus A/S deal

...stevia, vanillin and resveratrol for the food, nutrition and wellness sectors. EV-077 is an oral thromboxane receptor...
BioCentury | Sep 3, 2012
Clinical News

EV-077: Additional Phase IIa data

...SIX:EVE), Reinach, Switzerland Product: EV-077 Business: Cardiovascular Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
BioCentury | Aug 20, 2012
Clinical News

EV-077: Phase IIa data

...SIX:EVE), Reinach, Switzerland Product: EV-077 Business: Cardiovascular Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
BioCentury | Nov 14, 2011
Clinical News

EV-077: Phase IIa start

...SIX:EVE), Reinach, Switzerland Product: EV-077 Business: Endocrine/Metabolic Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
BioCentury | Aug 8, 2011
Clinical News

EV-077 cardiovascular data

...SIX:EVE), Reinach, Switzerland Product: EV-077 Business: Cardiovascular Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
BioCentury | Jul 25, 2011
Clinical News

EV-077: Phase I data

...Reinach, Switzerland Product: EV-077 Business: Cardiovascular, Renal Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
BioCentury | Mar 7, 2011
Clinical News

Evolva Holding preclinical data

...a greater reduction in clinical disease score compared to Tamiflu (70% vs. 30%). The oral thromboxane receptor...
BioCentury | Jan 3, 2011
Clinical News

EV-077: Phase I started

...Reinach, Switzerland Product: EV-077 Business: Cardiovascular, Renal Molecular target: Thromboxane receptor ; Thromboxane synthase Description: Oral thromboxane receptor...
Items per page:
1 - 10 of 19